Also known as: Psoriasis Vulgaris (Plaque Psoriasis)
Psoriasis is a chronic autoimmune skin condition that speeds up skin cell production.
Psoriasis is a chronic, immune-mediated inflammatory skin disease that affects approximately 2-3% of the global population, with an estimated 7.5 million adults affected in the United States. In psoriasis, the immune system mistakenly attacks healthy skin cells, dramatically accelerating the skin cell lifecycle. Normal skin cells grow and shed over the course of a month, but in psoriatic skin, this process occurs in just 3-4 days. The rapid accumulation of cells on the skin surface creates the characteristic thick, red patches covered with silvery-white scales known as plaques.
Plaque psoriasis, the most common form, accounts for approximately 80-90% of all psoriasis cases. Other types include guttate psoriasis (small, drop-shaped lesions often triggered by streptococcal infection), inverse psoriasis (smooth, red patches in skin folds), pustular psoriasis (pus-filled blisters), and erythrodermic psoriasis (widespread redness covering most of the body, a medical emergency). Psoriasis is not merely a cosmetic condition; it is a systemic disease associated with significant comorbidities including psoriatic arthritis, cardiovascular disease, metabolic syndrome, depression, and inflammatory bowel disease.
Psoriasis follows an unpredictable pattern of flares and remissions. Flares can be triggered by stress, infections (particularly streptococcal pharyngitis), certain medications (lithium, beta-blockers, antimalarials), skin trauma (Koebner phenomenon), cold weather, heavy alcohol consumption, and smoking. While there is no cure for psoriasis, significant advances in treatment over the past two decades, particularly biologic therapies that target specific immune pathways, have transformed outcomes for patients with moderate-to-severe disease. Many patients can now achieve near-complete or complete skin clearance with appropriate therapy.
People with Psoriasis often experience the following symptoms.
The hallmark of plaque psoriasis is well-defined, raised patches of red, inflamed skin covered with a silvery-white buildup of dead skin cells (scales). These plaques most commonly appear on the elbows, knees, scalp, and lower back but can occur anywhere on the body.
Psoriatic plaques often become severely dry and cracked, especially during winter months. These cracks or fissures can be deep enough to bleed, a phenomenon known as Auspitz sign when gentle removal of scales reveals pinpoint bleeding from the dilated capillaries beneath.
While not all psoriasis patients experience itching, many report significant pruritus that ranges from mild to severe. Some patients describe a burning or stinging sensation in affected areas. The discomfort can interfere with concentration, work, and sleep quality.
Up to 50% of psoriasis patients develop nail involvement. Changes include pitting (small dents or depressions), onycholysis (separation of the nail from the nail bed), subungual hyperkeratosis (thickening under the nail), discoloration, and crumbling of the nail plate. Nail psoriasis can be functionally impairing and cosmetically distressing.
Scalp psoriasis affects about 50% of patients and ranges from mild, fine scaling to thick, crusted plaques covering the entire scalp. It may extend beyond the hairline onto the forehead, neck, and around the ears. Severe scalp psoriasis can cause temporary hair loss.
Approximately 30% of psoriasis patients develop psoriatic arthritis, an inflammatory joint disease causing pain, swelling, and stiffness. It can affect any joint but commonly involves the fingers, toes, wrists, knees, and ankles. Early detection and treatment are crucial to prevent permanent joint damage.
New psoriatic lesions can develop at sites of skin injury, irritation, or trauma. This Koebner response means that scratches, sunburns, tattoos, vaccinations, or surgical wounds may trigger new plaques at those locations, typically within 10-14 days of the injury.
Certain factors may increase your likelihood of developing Psoriasis.
Common approaches to managing psoriasis. Always consult a healthcare provider for personalized treatment.
Topical steroids are the most commonly prescribed treatment for mild-to-moderate psoriasis. They reduce inflammation, slow skin cell turnover, and relieve itching. Available in various strengths, mild formulations are used for sensitive areas (face, groin) while stronger preparations treat thicker plaques on the body. Vitamin D analogues (calcipotriol) are often used in combination.
Controlled exposure to ultraviolet light is an effective treatment for moderate psoriasis. Narrowband UVB phototherapy is the most common approach, delivered in a dermatologist's office 2-3 times weekly. UV light slows the rapid skin cell growth and reduces inflammation. Excimer laser therapy delivers targeted UVB to individual plaques.
Biologics have revolutionized the treatment of moderate-to-severe psoriasis. These injectable or intravenous medications target specific components of the immune system. TNF-alpha inhibitors (adalimumab, etanercept), IL-17 inhibitors (secukinumab, ixekizumab), and IL-23 inhibitors (guselkumab, risankizumab) can achieve 75-100% skin clearance in many patients with excellent safety profiles.
Traditional systemic agents including methotrexate, cyclosporine, and acitretin are used for moderate-to-severe psoriasis when topical treatments are insufficient. Newer oral options include apremilast (a PDE4 inhibitor) and deucravacitinib (a TYK2 inhibitor), which offer improved safety profiles compared to older systemic agents.
Tazarotene, a topical retinoid, normalizes skin cell growth and reduces inflammation. Coal tar preparations, one of the oldest psoriasis treatments, remain effective for mild-to-moderate disease and are available over the counter. Anthralin (dithranol) is another topical option that slows skin cell growth.
Stress management, smoking cessation, limiting alcohol intake, maintaining a healthy weight, and regular moisturizing are important adjunctive measures. Some patients benefit from an anti-inflammatory diet. Regular moderate exercise and adequate sleep support overall immune health and may reduce flare frequency.
Psoriasis is typically diagnosed through clinical examination by a dermatologist based on the characteristic appearance and distribution of the skin lesions. The physician evaluates the morphology of plaques (well-defined, raised, red patches with silvery scales), their distribution pattern, and associated features such as nail changes and joint symptoms. A skin biopsy may be performed in atypical cases to confirm the diagnosis and differentiate psoriasis from other conditions such as eczema, seborrheic dermatitis, or fungal infections. Histologically, psoriatic skin shows epidermal hyperplasia, parakeratosis, and inflammatory cell infiltration. The Psoriasis Area and Severity Index (PASI) and Body Surface Area (BSA) measurements are used to quantify disease severity and guide treatment decisions. Blood tests may be ordered to screen for comorbidities and monitor systemic medications.
See a doctor if your psoriasis covers large areas of your body, if the condition is painful or interferes with daily life, if you develop joint pain or swelling (possible psoriatic arthritis), or if your current treatment is no longer effective.
Steps that may help reduce the risk of developing or worsening psoriasis.
Identify and avoid personal triggers including stress, infections, skin injuries, and specific medications known to provoke flares
Maintain consistent skin moisture by applying emollients regularly and avoiding harsh soaps, hot showers, and dry environments
Quit smoking and limit alcohol consumption, as both are proven to worsen psoriasis severity and reduce treatment effectiveness
Manage stress through relaxation techniques, mindfulness, regular exercise, and seeking mental health support when needed
Maintain a healthy body weight, as obesity is associated with more severe psoriasis and reduced response to treatment
If left untreated or poorly managed, psoriasis may lead to:
No, psoriasis is absolutely not contagious. You cannot catch psoriasis through physical contact, sharing personal items, or any other form of transmission. Psoriasis is an autoimmune condition caused by a combination of genetic susceptibility and environmental triggers. Unfortunately, misconceptions about contagiousness contribute to the social stigma that many psoriasis patients experience.
While both conditions cause red, inflamed, itchy skin, they have distinct characteristics. Psoriasis produces thick, well-defined, raised plaques with silvery scales, typically on the elbows, knees, and scalp. Eczema causes more diffuse, less sharply defined patches that are intensely itchy and may ooze, commonly in skin folds. Psoriasis is an autoimmune condition, while eczema involves skin barrier dysfunction. Treatment approaches differ significantly, making accurate diagnosis important.
Yes, psoriasis can go into periods of remission where symptoms significantly improve or disappear entirely. Remissions can last for weeks, months, or even years. Modern biologic treatments have made sustained remission achievable for many patients. However, psoriasis is a chronic condition, and flares can return, often triggered by stress, illness, or environmental factors. Ongoing maintenance therapy is often recommended to sustain remission.
Yes, psoriasis is a systemic inflammatory condition associated with several comorbidities. The most significant is psoriatic arthritis, affecting up to 30% of patients. Psoriasis patients also have increased risks of cardiovascular disease, metabolic syndrome (obesity, diabetes, high cholesterol), inflammatory bowel disease, depression, and certain cancers. Regular medical check-ups and proactive management of cardiovascular risk factors are recommended for all psoriasis patients.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.